Metabolite derivatives of the HDAC inhibitor FK228

Details for Australian Patent Application No. 2006318652 (hide)

Owner Gloucester Pharmaceuticals, Inc.

Inventors Verdine, Gregory L.; Or, Yat Sun; Keegan, Mitchell

Agent Davies Collison Cave

Pub. Number AU-A-2006318652

PCT Pub. Number WO2007/061939

Priority 60/738,284 18.11.05 US

Filing date 17 November 2006

Wipo publication date 31 May 2007

International Classifications

A61K 38/12 (2006.01) Medicinal preparations containing peptides - Cyclic peptides

C07K 5/12 (2006.01) Peptides having up to four amino acids in a fully defined sequence

Event Publications

5 June 2008 PCT application entered the National Phase

  PCT publication WO2007/061939 Priority application(s): WO2007/061939

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006318653-Method for detecting an inflammatory disease or cancer

2006318648-Micro-hydrocarbon analysis